Publi­ka­tio­nen

Publi­ka­tio­nen des Schwei­ze­ri­schen Hämo­phi­lie Netz­werks

Erlaub­te Medi­ka­men­te

SHN-Awards

  • 2020

    Titel: “Elu­ci­da­ting the asso­cia­ti­on bet­ween hae­mo­phi­lia and men­tal health pro­blems”

    Autoren: Dr. med. Mut­lu Kar­tal-Kaess et. al.

  • 2019

    Titel: “Obste­tri­cal out­co­mes in women suf­fe­ring from her­edi­ta­ry fibri­no­gen disorders”

    Autoren: Dr. med. Ales­san­dro Casi­ni et. al.

  • 2017

    Titel: “Throm­bo­dy­na­mics ana­ly­ser: a novel glo­bal coagu­la­ti­on assay to assess hemo­sta­tic com­pe­tence and moni­tor fac­tor repla­ce­ment in hae­mo­phi­lia”

    Autoren: Debo­ra Ber­tag­gia Cal­dera­ra et. al.

Wei­te­re SHN-Publi­ka­tio­nen

Ziele Hintergrund Bild
  • Titel: Manage­ment of blee­ding events and inva­si­ve pro­ce­du­res in pati­ents with hae­mo­phi­lia A wit­hout inhi­bi­tors trea­ted with emici­zu­mab
    A con­sen­sus state­ment of the Working Par­ty on Hae­mo­sta­sis of the Swiss Socie­ty of Hae­ma­to­lo­gy
    and the Swiss Hae­mo­phi­lia Net­work

    Autoren: Fon­ta­na Pierre, Alberio Loren­zo, Albi­set­ti Manue­la, Angel­il­lo-Scher­rer Anne, Asmis Lars M., Casi­ni Ales­san­dro, Ger­ber, Bern­hard, Graf Lukas, Hege­mann Inga, Kor­te Wolf­gang, Mar­ti­nez Maria, Studt Jan-Dirk, Tsa­ki­ris Dimi­tri­os, Wuil­l­emin Wal­ter, Kre­mer Hovin­ga Johan­na

    Arti­kel: WPH GUIDELINES EMICIZUMAB_FINAL

  • Titel: Impact of a pro­duct-spe­ci­fic refe­rence stan­dard for the mea­su­re­ment of a PEGy­la­ted rFVIII acti­vi­ty: the Swiss
    Mul­ti­cent­re Field Stu­dy

    Autoren: O. BULLA, A. PONCET, L. ALBERIO, L. M. ASMIS, A. GAHLER, L. GRAF, M.
    NAGLER, J.-D. STUDT, D. A. TSAKIRIS and P. FONTANA

    Arti­kel: BAX855_FINAL

Acro­bat Rea­der Pro­gramm

Um die Publi­ka­ti­on lesen und aus­dru­cken zu kön­nen, benö­ti­gen Sie den Ado­be Acro­bat-Rea­der. Die­ses kos­ten­lo­se Pro­gramm kön­nen Sie hier her­un­ter­la­den.